Kelly Jared
CIK 0002103581
Chief Executive OfficerDirector
Filings
3
Latest Jun 3, 2026
Issuers covered
1
Showing
3 of 3
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 100% | +15.1% | +15.3% | +20.5% | +9.4% |
| 90 days | 2 | 100% | +5.4% | +5.4% | +5.9% | +4.8% |
| 180 days | - | - | - | - | - | - |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Kelly Jared has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ONCY | Oncolytics Biotech Inc | 3 | Jun 3, 2026 |
All filings
3 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|